Cy A. Stein

3.5k total citations · 1 hit paper
51 papers, 2.3k citations indexed

About

Cy A. Stein is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Cy A. Stein has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Cy A. Stein's work include Prostate Cancer Treatment and Research (15 papers), RNA Interference and Gene Delivery (9 papers) and DNA and Nucleic Acid Chemistry (9 papers). Cy A. Stein is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), RNA Interference and Gene Delivery (9 papers) and DNA and Nucleic Acid Chemistry (9 papers). Cy A. Stein collaborates with scholars based in United States, Switzerland and Denmark. Cy A. Stein's co-authors include Daniela Castanotto, Jack S. Cohen, Arthur Μ. Krieg, Samuel Broder, Charles E. Myers, Carlo M. Croce, C. Subasinghe, John C. Reed, Subrata Haldar and C. Majumdar and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Cy A. Stein

50 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA-Approved Oligonucleotide Therapies in 2017

2017 492 citations Cy A. Stein, Daniela Castanotto Molecular Therapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Cy A. Stein	1.6k	351	268	263	177	51	2.3k
Tracy R. Daniels‐Wells	1.5k 1.0×	553 1.6×	187 0.7×	266 1.0×	494 2.8×	51	3.0k
Glenn M. Swartz	975 0.6×	333 0.9×	536 2.0×	142 0.5×	351 2.0×	40	2.1k
C. Chandra Kumar	1.8k 1.1×	449 1.3×	322 1.2×	148 0.6×	218 1.2×	43	2.5k
Peter Teriete	1.0k 0.7×	267 0.8×	273 1.0×	83 0.3×	303 1.7×	44	1.9k
George E. Durán	958 0.6×	860 2.5×	263 1.0×	141 0.5×	168 0.9×	54	1.7k
Dominik A. Megger	1.1k 0.7×	365 1.0×	257 1.0×	86 0.3×	184 1.0×	47	1.7k
John Sensintaffar	2.0k 1.2×	424 1.2×	284 1.1×	473 1.8×	480 2.7×	29	2.8k
Jonathan R. Hart	1.5k 0.9×	538 1.5×	312 1.2×	102 0.4×	150 0.8×	47	1.9k
William McCulloch	1.4k 0.9×	484 1.4×	512 1.9×	226 0.9×	277 1.6×	87	2.5k
Sharlyn J. Mazur	2.3k 1.4×	849 2.4×	351 1.3×	74 0.3×	139 0.8×	48	2.8k

Countries citing papers authored by Cy A. Stein

Since Specialization

Citations

This map shows the geographic impact of Cy A. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cy A. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cy A. Stein more than expected).

Fields of papers citing papers by Cy A. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cy A. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cy A. Stein. The network helps show where Cy A. Stein may publish in the future.

Co-authorship network of co-authors of Cy A. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Cy A. Stein. A scholar is included among the top collaborators of Cy A. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cy A. Stein. Cy A. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorff, Tanya B., Cy A. Stein, Marcin Kortylewski, et al.. (2020). Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 35(7). 485–489. 3 indexed citations

Castanotto, Daniela, Xiaowei Zhang, Jessica Alluin, et al.. (2020). A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa Cells. Molecular Therapy — Nucleic Acids. 23. 63–75. 5 indexed citations

Castanotto, Daniela, et al.. (2019). Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017–2019. Trends in Pharmacological Sciences. 41(1). 27–41. 68 indexed citations

Stein, Cy A., Richard Levin, Robert Given, et al.. (2017). Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. Urologic Oncology Seminars and Original Investigations. 36(2). 81.e9–81.e16. 14 indexed citations

Stein, Cy A., Daniela Castanotto, Amrita Krishnan, & Liana Nikolaenko. (2016). Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs. Molecular Therapy — Nucleic Acids. 5. e346–e346. 22 indexed citations

Castanotto, Daniela & Cy A. Stein. (2014). Antisense oligonucleotides in cancer. Current Opinion in Oncology. 26(6). 584–589. 50 indexed citations

Pal, Sumanta K., Cy A. Stein, & Oliver Sartor. (2013). Enzalutamide for the treatment of prostate cancer. Expert Opinion on Pharmacotherapy. 14(5). 679–685. 20 indexed citations

Eroglu, Zeynep, Cy A. Stein, & Sumanta K. Pal. (2013). Targeting angiopoietin-2 signaling in cancer therapy. Expert Opinion on Investigational Drugs. 22(7). 813–825. 31 indexed citations

Souleimanian, Naira E., Glen F. Deleavey, Harris S. Soifer, et al.. (2012). Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids. Molecular Therapy — Nucleic Acids. 1. e43–e43. 55 indexed citations

10.

Hsu, Joann, et al.. (2012). Preoperative therapy for localized prostate cancer: A comprehensive overview. Maturitas. 74(1). 3–9. 6 indexed citations

11.

Soifer, Harris S., et al.. (2011). Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells. Journal of Biological Chemistry. 287(6). 3777–3787. 62 indexed citations

12.

Lai, Johnathan C., Bob D. Brown, Stefan Vonhoff, et al.. (2007). Comparison of D-G3139 and Its Enantiomer L-G3139 in Melanoma Cells Demonstrates Minimal In Vitro but Dramatic In Vivo Chiral Dependency. Molecular Therapy. 15(2). 270–278. 7 indexed citations

13.

Cho‐Chung, Yoon S., Alan M. Gewirtz, & Cy A. Stein. (2005). Therapeutic oligonucleotides : transcriptional and translational strategies for silencing gene expression. New York Academy of Sciences eBooks. 2 indexed citations

14.

Turelli, Priscilla, et al.. (2001). Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles. Pharmaceutical Research. 18(8). 1096–1101. 23 indexed citations

15.

Allémann, Éric, et al.. (1999). Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. European Journal of Pharmaceutical Sciences. 9(2). 163–170. 30 indexed citations

16.

Stein, Cy A. & Arthur Μ. Krieg. (1998). Applied antisense oligonucleotide technology. 124 indexed citations

17.

Stein, Cy A. & Ramaswamy Narayanan. (1994). Antisense oligodeoxynucleotides. Current Opinion in Oncology. 6(6). 587–594. 33 indexed citations

18.

Chou, Ting‐Chao, et al.. (1991). Differential Alteration of the Anti-HIV-1 Effect of Phosphorothioate Oligonucleotide S-dC28 by AZT, Interferon-Alpha, and Dextran Sulfate. AIDS Research and Human Retroviruses. 7(11). 943–951. 7 indexed citations

19.

Majumdar, C., Cy A. Stein, Jack S. Cohen, Samuel Broder, & Samuel H. Wilson. (1989). Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry. 28(3). 1340–1346. 160 indexed citations

20.

Holland, Edward J., Cy A. Stein, Alan G. Palestine, et al.. (1988). Suramin Keratopathy. American Journal of Ophthalmology. 106(2). 216–220. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact